Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (541-550 of 941) with videos related to

Pageof 95
Sort By:
Cancer Gene Therapy|July 30, 2005
Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoterD Yu, C Scott, W W Jia, et al.
Molecular and Cellular Endocrinology|February 5, 2014
Insulin-like growth factor-I induces CLU expression through Twist1 to promote prostate cancer growthArio Takeuchi, Masaki Shiota, Eliana Beraldi, et al.
The Prostate|February 8, 2013
Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancerMarie-Odile Guimond, Marie-Claude Battista, Fatemeh Nikjouitavabi, et al.
Psychotherapy (Chicago, Ill.)|June 5, 2018
Practice-based evidence can help! Using the Group Questionnaire to enhance clinical practiceDerek Griner, Mark E Beecher, Loren B Brown, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 2, 2017
Quantification of large scale DNA organization for predicting prostate cancer recurrenceCalum MacAulay, Mira Keyes, Malcolm Hayes, et al.
European Urology|May 16, 2016
SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway InhibitionYinan Li, Nilgun Donmez, Cenk Sahinalp, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 25, 2018
Natural history of prostatic lesions on serial multiparametric magnetic resonance imagingSamrad Ghavimi, Hamidreza Abdi, Jennifer Waterhouse, et al.
The Prostate|October 25, 2016
Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer ProgressionTakashi Dejima, Kenjiro Imada, Ario Takeuchi, et al.
Plant Methods|December 20, 2005
Transient expression vectors for functional genomics, quantification of promoter activity and RNA silencing in plantsRoger P Hellens, Andrew C Allan, Ellen N Friel, et al.
Experimental Cell Research|August 23, 2005
Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitroPaulo Ferreira, Maria José Oliveira, Eliana Beraldi, et al.
Pageof 95

Showing results (541-550 of 941) with videos related to

Sort By:
Pageof 95
Cancer Gene Therapy|July 30, 2005
Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoterD Yu, C Scott, W W Jia, et al.
Molecular and Cellular Endocrinology|February 5, 2014
Insulin-like growth factor-I induces CLU expression through Twist1 to promote prostate cancer growthArio Takeuchi, Masaki Shiota, Eliana Beraldi, et al.
The Prostate|February 8, 2013
Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancerMarie-Odile Guimond, Marie-Claude Battista, Fatemeh Nikjouitavabi, et al.
Psychotherapy (Chicago, Ill.)|June 5, 2018
Practice-based evidence can help! Using the Group Questionnaire to enhance clinical practiceDerek Griner, Mark E Beecher, Loren B Brown, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 2, 2017
Quantification of large scale DNA organization for predicting prostate cancer recurrenceCalum MacAulay, Mira Keyes, Malcolm Hayes, et al.
European Urology|May 16, 2016
SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway InhibitionYinan Li, Nilgun Donmez, Cenk Sahinalp, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 25, 2018
Natural history of prostatic lesions on serial multiparametric magnetic resonance imagingSamrad Ghavimi, Hamidreza Abdi, Jennifer Waterhouse, et al.
The Prostate|October 25, 2016
Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer ProgressionTakashi Dejima, Kenjiro Imada, Ario Takeuchi, et al.
Plant Methods|December 20, 2005
Transient expression vectors for functional genomics, quantification of promoter activity and RNA silencing in plantsRoger P Hellens, Andrew C Allan, Ellen N Friel, et al.
Experimental Cell Research|August 23, 2005
Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitroPaulo Ferreira, Maria José Oliveira, Eliana Beraldi, et al.
Pageof 95